| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/04/1997 | US5599693 Culture product |
| 02/04/1997 | US5599692 Antigenic polypeptides of Taenia ovis |
| 02/04/1997 | US5599691 Herpes simplex virus as a vector |
| 02/04/1997 | US5599690 Using high concentration of leucine and, or methionine in culture |
| 02/04/1997 | US5599686 Oligopeptide comprising sequence of amino acids recognized and selectively proteolytically cleaved by free prostate specific antigen |
| 02/04/1997 | US5599680 Diagnostic applications of mouse ascites golgi (MAG) manipulation |
| 02/04/1997 | US5599679 A polypeptide for immuno-competing binding; immunoassay diagnosing bone disorder |
| 02/04/1997 | US5599678 Antibodies which react with fibrinogen fragments E1, E2 and E3 and methods of their use |
| 02/04/1997 | US5599676 Method for isolating a novel receptor for α4 integrins |
| 02/04/1997 | US5599673 Long QT syndrome genes |
| 02/04/1997 | US5599671 Human A2B adenosine receptor assay |
| 02/04/1997 | US5599670 β-glucuronidase and glucuronide permease gene system |
| 02/04/1997 | US5599669 Cytokine-induced marker for inflammatory response |
| 02/04/1997 | US5599665 Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection |
| 02/04/1997 | US5599560 Method of treating depression using neurotrophins |
| 02/04/1997 | US5599559 Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it |
| 02/04/1997 | US5599544 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1997 | US5599543 Preventing malaria |
| 02/04/1997 | US5599542 Diagnosis, treatment and vaccine for malaria; induction of antibodies that attack plasmodium in the schizont stage |
| 02/04/1997 | US5599541 Peptide sequence capable of inducing a delayed-type hypersensitivity reaction in the presence of living bacteria of the Mycobacterium tuberculosis complex and its applications |
| 02/04/1997 | US5599539 Administering avian antitoxin |
| 02/04/1997 | US5599538 Catalyzing the hydrolysis of the peptide bonde between amino acid residues, e.g. the vasoactive intestinal peptide; anticarcinogenic agents; viricides; bactericides; protozoa; medical diagnosis |
| 02/04/1997 | US5599537 Salmonella virulence genes |
| 02/04/1997 | CA2071425C Prophylactic/therapeutic composition for disseminated intravascular coagulation, or chronic respiratory tract infectious disease |
| 01/30/1997 | WO1997003360A1 HELICOBACTER VACCINE ANTIGEN RECOGNIZED BY A PROTECTIVE MONOCLONAL ANTIBODY (IgG 50) |
| 01/30/1997 | WO1997003359A1 Helicobacter clpb |
| 01/30/1997 | WO1997003358A1 Method of identifying inhibitors of the jak-stat signal transduction pathway |
| 01/30/1997 | WO1997003203A2 Generation of immune responses to prostate-specific antigen (psa) |
| 01/30/1997 | WO1997003200A1 Nucleic acid coding for cmp-n-acetyl-neuraminic acid hydroxylase and its use for the production of modified glycoproteins |
| 01/30/1997 | WO1997003199A1 Herpes simplex virus glycoprotein d variants |
| 01/30/1997 | WO1997003198A2 Nucleotide and amino acid sequence and uses thereof |
| 01/30/1997 | WO1997003197A1 Novel secretion factors for gram-positive microorganisms, genes encoding them and methods of using it |
| 01/30/1997 | WO1997003196A1 CLONING, TISSUE DISTRIBUTION, AND FUNCTIONAL ANALYSIS OF Na+/H+ EXCHANGER ISOFORM, NHE3 |
| 01/30/1997 | WO1997003195A1 Novel factor viii:c polypeptide analogs with altered protease sites |
| 01/30/1997 | WO1997003194A1 Lysine 1689 factor viii:c polypeptide analogs |
| 01/30/1997 | WO1997003193A1 Novel factor viii:c polypeptide analogs with altered metal-binding properties |
| 01/30/1997 | WO1997003192A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | WO1997003191A1 Novel factor viii:c polypeptide analogs comprising factor v domains or subdomains |
| 01/30/1997 | WO1997003190A1 HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1997003187A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | WO1997003186A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 01/30/1997 | WO1997003183A1 Pap mutants that exhibit anti-viral and/or anti-fungal activity in plants |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1997003089A2 Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin a and b chains |
| 01/30/1997 | WO1997003087A1 Novel regulatory genes |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997002841A1 Genetic therapy employing the hhv-6a derived ts gene or polypeptide |
| 01/30/1997 | WO1997002836A1 Clostridium difficile toxins as mucosal adjuvants |
| 01/30/1997 | WO1997002834A1 Analogs of parathyroid hormone |
| 01/30/1997 | WO1997002737A1 Cytoplasmic male sterility system producing canola hybrids |
| 01/30/1997 | WO1997002730A2 Enamel matrix related polypeptide |
| 01/30/1997 | WO1996041815A3 CONJUGATES OF αMSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 01/30/1997 | WO1996041607A3 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
| 01/30/1997 | WO1996039523A3 Bacterial production of hydrophobic polypeptides |
| 01/30/1997 | WO1996039513A3 Ebnerin cloning of a secreted von ebner's gland protein |
| 01/30/1997 | WO1996039429A3 Serum protein produced exclusively in adipocytes |
| 01/30/1997 | WO1996039423A3 A method for increasing the electrotransport flux of polypeptides |
| 01/30/1997 | WO1996038555A3 Unc-53 from c. elegans and its uses in testing compounds involved in the control fo cell behaviour and pharmaceutical compositions |
| 01/30/1997 | DE19527129A1 Arzneimittel enthaltend wenigstens einen Teil des UL84-Proteins des Cytomegalovirus, Verwendung von Polypeptiden entsprechend der Aminosäuresequenz des UL84-Proteins und Verfahren zur Einführung von UL84 in Zielzellen Medicament comprising at least one part of the UL84 protein of cytomegalovirus, use of polypeptides according to the amino acid sequence of the UL84 protein and method for introducing into target cells UL84 |
| 01/30/1997 | CA2273137A1 Cytoplasmic male sterility system producing canola hybrids |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | CA2226570A1 Enamel matrix related polypeptide |
| 01/30/1997 | CA2226490A1 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 01/30/1997 | CA2226362A1 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | CA2226339A1 Clostridium difficile toxins as mucosal adjuvants |
| 01/30/1997 | CA2226255A1 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/29/1997 | EP0756006A2 Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof |
| 01/29/1997 | EP0756005A1 Gene coding for adseverins |
| 01/29/1997 | EP0755943A1 Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus |
| 01/29/1997 | EP0755683A1 Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen |
| 01/29/1997 | EP0755682A1 Methods of treatment of motor neuron diseases using members of the BDNF/NT-3/NGF family of molecules |
| 01/29/1997 | EP0755517A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
| 01/29/1997 | EP0755454A1 Aav-mediated delivery of dna to cells of the nervous system |
| 01/29/1997 | EP0755452A1 Method and composition for regulating apoptosis |
| 01/29/1997 | EP0755451A1 Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 01/29/1997 | EP0755447A1 RECOMBINANT PROTEINS OF FILAMENTOUS HAEMAGGLUTININ OF $i(BORDETELLA), PARTICULARLY $i(BORDETELLA PERTUSSIS), METHOD FOR PRODUCING SAME, AND USES THEREOF FOR PRODUCING FOREIGN PROTEINS OR VACCINATING ACTIVE PRINCIPLES |
| 01/29/1997 | EP0755446A1 Cardiotrophin and uses therefor |
| 01/29/1997 | EP0755445A1 Cell-cycle regulatory proteins, and uses related thereto |
| 01/29/1997 | EP0755443A1 Tissue-specific enhancer active in prostate |
| 01/29/1997 | EP0755441A1 Antibacterial therapy with genotypically modified bacteriophage |
| 01/29/1997 | EP0755440A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 01/29/1997 | EP0755438A1 Method for controlling metallophosphate precipitation in high cell density fermentations |
| 01/29/1997 | EP0755408A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 01/29/1997 | EP0755407A1 Pharmaceutical peptide formulations for treatment of dust mite allergy |
| 01/29/1997 | EP0755403A1 Method of separating protective components of bordetella pertussis |
| 01/29/1997 | EP0755268A1 Compositions and methods for gene therapy to treat disease |
| 01/29/1997 | EP0755266A1 An adjuvant |
| 01/29/1997 | EP0755263A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/29/1997 | EP0755259A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 01/29/1997 | EP0723453A4 Method of treating reproductive disorders |
| 01/29/1997 | EP0673256A4 Suppression of myeloid cells. |
| 01/29/1997 | EP0666768B1 A liquid chromatographic system |
| 01/29/1997 | EP0644772A4 Opioid peptides. |
| 01/29/1997 | EP0604605A4 Treating disorders by application of insulin-like growth factors and analogs. |
| 01/29/1997 | EP0542897B1 Producing monoclonal antibodies against human Vbeta T-cell receptor element using recombinant DNA vectors |
| 01/29/1997 | EP0493446B1 Treatment of autoimmune disease |
| 01/29/1997 | EP0477290B1 Methods, compositions and devices for growing cells |
| 01/29/1997 | EP0112342B1 Novel ice nucleating microorganisms |